$2.57B
$554 Million
0.15% of portfolio
10,494
Q3 2024
Reduced 57.95%
$1.84B
$548 Million
0.15% of portfolio
17,115
Q3 2024
New
$13.4B
$556 Million
0.15% of portfolio
2,302
Q3 2024
New
$5.2B
$571 Million
0.15% of portfolio
4,221
Q3 2024
New
$1.7B
$552 Million
0.15% of portfolio
37,738
Q3 2024
New
-
$556 Million
0.15% of portfolio
-
Q3 2024
Reduced 14.99%
$5.05B
$511 Million
0.14% of portfolio
5,146
Q3 2024
Added 37.67%
$34.7B
$532 Million
0.14% of portfolio
6,631
Q3 2024
New
$129B
$514 Million
0.14% of portfolio
13,815
Q3 2024
New
$1.44B
$529 Million
0.14% of portfolio
39,009
Q3 2024
New
$580M
$539 Million
0.14% of portfolio
8,262
Q3 2024
New
$2.88B
$512 Million
0.14% of portfolio
36,072
Q3 2024
Reduced 70.32%
$13.2B
$523 Million
0.14% of portfolio
2,962
Q3 2024
Added 112.94%
$4B
$534 Million
0.14% of portfolio
5,075
Q3 2024
Added 0.51%
$9.15B
$512 Million
0.14% of portfolio
17,871
Q3 2024
New
$20.7B
$493 Million
0.13% of portfolio
6,840
Q3 2024
New
$642M
$486 Million
0.13% of portfolio
69,830
Q3 2024
New
$1.34B
$498 Million
0.13% of portfolio
20,090
Q3 2024
Added 3.44%
$101B
$474 Million
0.13% of portfolio
7,495
Q3 2024
Reduced 54.06%
$1.08B
$474 Million
0.13% of portfolio
26,589
Q3 2024
New
$6.02B
$497 Million
0.13% of portfolio
15,772
Q3 2024
Reduced 62.22%
$950M
$470 Million
0.13% of portfolio
80,410
Q3 2024
New
$1.28B
$503 Million
0.13% of portfolio
11,661
Q3 2024
Reduced 13.29%
$698M
$445 Million
0.12% of portfolio
13,446
Q3 2024
Added 23.66%
$1.63B
$465 Million
0.12% of portfolio
8,064
Q3 2024
New
$610M
$461 Million
0.12% of portfolio
27,328
Q3 2024
Added 33.52%
$105B
$467 Million
0.12% of portfolio
4,505
Q3 2024
Added 112.2%
$13.2B
$465 Million
0.12% of portfolio
2,789
Q3 2024
Reduced 79.17%
$4.46B
$448 Million
0.12% of portfolio
12,752
Q3 2024
New
$26.8B
$436 Million
0.12% of portfolio
3,998
Q3 2024
New
$2.68B
$442 Million
0.12% of portfolio
9,802
Q3 2024
Reduced 46.51%
$1.01B
$438 Million
0.12% of portfolio
4,087
Q3 2024
New
-
$432 Million
0.12% of portfolio
-
Q3 2024
Reduced 64.24%
$470M
$434 Million
0.12% of portfolio
22,699
Q3 2024
Added 2.89%
$5.8B
$446 Million
0.12% of portfolio
4,514
Q3 2024
Added 8.93%
$19.6B
$460 Million
0.12% of portfolio
15,764
Q3 2024
Reduced 48.12%
Neumora Therapeutics Inc.
-
$466 Million
0.12% of portfolio
-
Q3 2024
New
$8.23B
$453 Million
0.12% of portfolio
2,484
Q3 2024
Reduced 5.15%
$1.49B
$457 Million
0.12% of portfolio
13,384
Q3 2024
Added 3.03%
$3.36B
$435 Million
0.12% of portfolio
25,857
Q3 2024
Reduced 89.94%
$147B
$404 Million
0.11% of portfolio
6,232
Q3 2024
New
$29B
$402 Million
0.11% of portfolio
41
Q3 2024
New
$2.28B
$402 Million
0.11% of portfolio
14,451
Q3 2024
New
$8.04B
$410 Million
0.11% of portfolio
23,339
Q3 2024
Reduced 12.88%
$1.15B
$405 Million
0.11% of portfolio
71,337
Q3 2024
Reduced 49.98%
$5.54B
$418 Million
0.11% of portfolio
11,516
Q3 2024
Reduced 19.07%
$910M
$420 Million
0.11% of portfolio
11,609
Q3 2024
New
$591M
$373 Million
0.1% of portfolio
8,515
Q3 2024
Reduced 49.04%
$1.91B
$373 Million
0.1% of portfolio
17,088
Q3 2024
New
$1.73B
$363 Million
0.1% of portfolio
125,927
Q3 2024
Added 494.0%